Galanin Receptor Type 2 (GALR2) Antibody
221€ (50 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Galanin Receptor Type 2 (GALR2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx329775
tested applications
ELISA, WB
Description
GALR2 Antibody is a Rabbit Polyclonal against GALR2.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Galanin Receptor Type 2 (GALR2) |
| Host | Rabbit |
| Reactivity | Human, Mouse, Rat |
| Recommended Dilution | WB: 1/500 - 1/1000. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Purified by affinity chromatography. |
| Size 1 | 50 µg |
| Size 2 | 100 µg |
| Form | Liquid |
| Tested Applications | ELISA, WB |
| Buffer | PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | O43603 |
| Gene ID | 8811 |
| OMIM | 603691 |
| Alias | GALR2,GALNR2,GALR-2,GAL2 receptor |
| Background | Antibody anti-GALR2 |
| Status | RUO |
Descripción
GALR2 is a G protein-coupled receptor for the neuropeptide galanin that can couple to both Gi/o and Gq/11 proteins, allowing it to activate diverse signaling pathways. Through Gi/o coupling, GALR2 inhibits cAMP production, whereas Gq/11 coupling activates phospholipase C (PLC), leading to calcium mobilization and protein kinase C (PKC) activation. GALR2 is highly expressed in the CNS, particularly in the hypothalamus, amygdala, and dorsal root ganglia, where it regulates pain transmission, feeding behavior, and neuroprotection. GALR2 plays a pro-survival role in neurodegenerative conditions by promoting neuronal growth and survival in response to injury. In the peripheral nervous system, GALR2 mediates pain signaling, including both pro- and anti-nociceptive effects depending on tissue and receptor localization. GALR2 also promotes angiogenesis, proliferation, and survival in various cancers, including head and neck cancers, where its overexpression is associated with tumor progression. Dysregulation of GALR2 contributes to mood disorders, epilepsy, and neuropathic pain, making it a potential therapeutic target for neurodegenerative diseases, mood regulation, and cancer therapy.
Related Products
Galanin Receptor Type 2 (GALR2) Antibody
GALR2 Antibody is a Rabbit Polyclonal against GALR2.
Ver ProductoGalanin Receptor Type 2 (GALR2) Antibody
GALR2 Antibody is a Rabbit Polyclonal against GALR2.
Ver ProductoGalanin Receptor Type 2 (GALR2) Antibody
Galanin Receptor Type 2 (GALR2) Antibody is a Rabbit Polyclonal antibody for the detection of Human GALR2.
Ver Producto